Beiträge

Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy

Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial

An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins

Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007

Host mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application

Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy

Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma

Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ

Tumor selective replication of Newcastle disease virus: association with defects of tumor cells in antiviral defence